cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
PAAD	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	15.39	6.96e-33	0.97	0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	15.39	6.96e-33	0.97	0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-15.25	1.6e-32	-0.96	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-15.25	1.6e-32	-0.96	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-15.25	1.6e-32	-0.96	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-15.25	1.6e-32	-0.96	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-15.25	1.6e-32	-0.96	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-15.25	1.6e-32	-0.96	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-15.22	1.89e-32	-0.96	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-15.22	1.89e-32	-0.96	-0.78	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-14.95	1.02e-31	-0.95	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-14.95	1.02e-31	-0.95	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-14.95	1.02e-31	-0.95	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-14.95	1.02e-31	-0.95	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-14.92	1.2e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-14.92	1.2e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-14.92	1.2e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-14.92	1.2e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	14.92	1.2e-31	0.94	0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	14.92	1.2e-31	0.94	0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-14.84	1.93e-31	-0.95	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-14.84	1.93e-31	-0.95	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-14.73	3.95e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-14.73	3.95e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-14.7	4.7e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-14.7	4.7e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-14.7	4.7e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-14.7	4.7e-31	-0.94	-0.77	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-14.54	1.21e-30	-0.94	-0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-14.54	1.21e-30	-0.94	-0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-14.53	1.29e-30	-0.92	-0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-14.53	1.29e-30	-0.92	-0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-14.37	3.43e-30	-0.91	-0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-14.37	3.43e-30	-0.91	-0.76	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-13.82	1.03e-28	-0.91	-0.75	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-13.82	1.03e-28	-0.91	-0.75	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-12.93	2.63e-26	-0.93	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-12.93	2.63e-26	-0.93	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-12.93	2.63e-26	-0.93	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-12.93	2.63e-26	-0.93	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-12.19	2.64e-24	-0.91	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-12.19	2.64e-24	-0.91	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-11.96	1.08e-23	-0.9	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-11.96	1.08e-23	-0.9	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-11.85	2.13e-23	-0.91	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-11.85	2.13e-23	-0.91	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
PAAD	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	11.45	2.51e-22	1	0.68	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	11.45	2.51e-22	1	0.68	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	11.25	8.68e-22	1.04	0.67	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	11.19	1.27e-21	1.04	0.67	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	11.03	3.4e-21	0.98	0.67	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	11	4.26e-21	0.98	0.66	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	10.96	5.24e-21	0.98	0.66	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	10.96	5.3e-21	0.99	0.66	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	10.96	5.3e-21	0.99	0.66	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	10.96	5.3e-21	0.99	0.66	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	10.93	6.45e-21	0.99	0.66	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	10.93	6.45e-21	0.99	0.66	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	10.93	6.45e-21	0.99	0.66	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
PAAD	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	10.93	6.54e-21	0.98	0.66	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	10.64	3.78e-20	1.18	0.65	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	10.54	7.19e-20	1.2	0.65	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	10.54	7.19e-20	1.2	0.65	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	10.52	8.1e-20	1.2	0.65	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
PAAD	cis	rs75358501	0.748	rs12470963	MIMAT0014995	hsa-miR-3130-5p	-9.6	2.22e-17	-0.84	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.748	rs12470963	MIMAT0014995_1	hsa-miR-3130-5p	-9.6	2.22e-17	-0.84	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783246~206783266:+
PAAD	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	9.32	1.25e-16	1.02	0.6	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs6849357	MIMAT0003242	hsa-miR-577	-9.22	2.25e-16	-1	-0.6	Hemoglobin concentration;	chr4:114598115	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13112553	MIMAT0003242	hsa-miR-577	-9.22	2.25e-16	-1	-0.6	Hemoglobin concentration;	chr4:114598194	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-9.22	2.25e-16	-1	-0.6	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.516	rs11098259	MIMAT0003242	hsa-miR-577	-9.22	2.25e-16	-1	-0.6	Hemoglobin concentration;	chr4:114598669	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.56	rs11098260	MIMAT0003242	hsa-miR-577	-9.22	2.25e-16	-1	-0.6	Hemoglobin concentration;	chr4:114598670	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	9.15	3.37e-16	1	0.59	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	9.12	3.93e-16	0.99	0.59	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-9.12	3.93e-16	-0.99	-0.59	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	9.12	4.16e-16	1	0.59	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	9.1	4.46e-16	0.93	0.59	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	9.1	4.46e-16	0.93	0.59	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	9.1	4.46e-16	0.93	0.59	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-9.06	5.7e-16	-0.81	-0.59	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	9.05	6.09e-16	1	0.59	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	9.05	6.09e-16	1	0.59	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	9.05	6.09e-16	1	0.59	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	9.05	6.09e-16	1	0.59	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	9.05	6.09e-16	1	0.59	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	9.05	6.09e-16	1	0.59	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	9.05	6.22e-16	0.99	0.59	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-8.92	1.37e-15	-0.84	-0.58	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	8.88	1.65e-15	0.96	0.58	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	8.65	6.41e-15	0.84	0.57	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-8.56	1.13e-14	-0.79	-0.57	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-8.56	1.13e-14	-0.79	-0.57	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	8.56	1.13e-14	0.79	0.57	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	7.5	4.77e-12	0.79	0.52	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	7.5	4.77e-12	0.79	0.52	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-7.25	1.96e-11	-0.64	-0.51	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
PAAD	cis	rs7894407	0.634	rs755577	MIMAT0005951	hsa-miR-1307-3p	7.07	5.05e-11	0.41	0.5	White matter hyperintensity burden;	chr10:103464309	chr10:103394301~103394322:-
PAAD	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-7.05	5.88e-11	-0.62	-0.49	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-7.05	5.88e-11	-0.62	-0.49	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-7.05	5.88e-11	-0.62	-0.49	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-7.05	5.88e-11	-0.62	-0.49	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
PAAD	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-7.05	5.88e-11	-0.62	-0.49	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
PAAD	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-6.97	8.73e-11	-0.36	-0.49	Migraine;	chr10:103279822	chr10:103394301~103394322:-
PAAD	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-6.96	9.57e-11	-0.61	-0.49	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
PAAD	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-6.94	1.05e-10	-0.36	-0.49	Migraine;	chr10:103273871	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-6.84	1.75e-10	-0.39	-0.48	Migraine;	chr10:103338267	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-6.79	2.39e-10	-0.38	-0.48	Migraine;	chr10:103286250	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-6.79	2.39e-10	-0.38	-0.48	Migraine;	chr10:103286932	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-6.79	2.39e-10	-0.38	-0.48	Migraine;	chr10:103295206	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-6.79	2.39e-10	-0.38	-0.48	Migraine;	chr10:103296155	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-6.79	2.39e-10	-0.38	-0.48	Migraine;	chr10:103315955	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-6.79	2.39e-10	-0.38	-0.48	Migraine;	chr10:103365694	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-6.79	2.39e-10	-0.38	-0.48	Migraine;	chr10:103369141	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-6.74	3.09e-10	-0.38	-0.48	Migraine;	chr10:103394332	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-6.73	3.21e-10	-0.38	-0.48	Migraine;	chr10:103254113	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-6.72	3.4e-10	-0.36	-0.48	Migraine;	chr10:103284207	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-6.69	3.92e-10	-0.36	-0.48	Migraine;	chr10:103283532	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-6.67	4.28e-10	-0.35	-0.47	Migraine;	chr10:103241568	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	6.67	4.49e-10	0.35	0.47	Migraine;	chr10:103238157	chr10:103394301~103394322:-
PAAD	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-6.66	4.72e-10	-0.8	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-6.66	4.72e-10	-0.8	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-6.6	6.4e-10	-0.8	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-6.6	6.4e-10	-0.8	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
PAAD	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	6.59	6.54e-10	0.37	0.47	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	6.47	1.27e-09	0.37	0.46	Migraine;	chr10:103236031	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-6.42	1.64e-09	-0.36	-0.46	Migraine;	chr10:103415374	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-6.38	1.95e-09	-0.34	-0.46	Migraine;	chr10:103289348	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-6.38	1.95e-09	-0.34	-0.46	Migraine;	chr10:103292867	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-6.38	1.95e-09	-0.34	-0.46	Migraine;	chr10:103293183	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-6.38	1.95e-09	-0.34	-0.46	Migraine;	chr10:103293219	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-6.19	5.25e-09	-0.34	-0.45	Migraine;	chr10:103262005	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-6.19	5.25e-09	-0.34	-0.45	Migraine;	chr10:103270083	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	6.19	5.25e-09	0.34	0.45	Migraine;	chr10:103261506	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-6.18	5.55e-09	-0.34	-0.45	Migraine;	chr10:103299082	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	6.1	8.18e-09	0.34	0.44	Migraine;	chr10:103244344	chr10:103394301~103394322:-
PAAD	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	6.06	1.01e-08	0.63	0.44	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
PAAD	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	5.96	1.7e-08	0.35	0.43	Migraine;	chr10:103263177	chr10:103394301~103394322:-
PAAD	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	5.95	1.79e-08	0.86	0.43	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
PAAD	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	5.94	1.86e-08	0.33	0.43	Migraine;	chr10:103240612	chr10:103394301~103394322:-
PAAD	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	5.83	3.12e-08	0.62	0.43	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	5.7	5.96e-08	0.6	0.42	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	5.7	5.96e-08	0.6	0.42	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	5.7	5.96e-08	0.6	0.42	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	5.7	5.96e-08	0.6	0.42	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	5.7	5.96e-08	0.6	0.42	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
PAAD	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-5.67	6.76e-08	-0.32	-0.42	Migraine;	chr10:103317367	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-5.67	6.76e-08	-0.32	-0.42	Migraine;	chr10:103319682	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-5.67	7e-08	-0.32	-0.42	Migraine;	chr10:103284400	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-5.66	7.22e-08	-0.31	-0.42	Migraine;	chr10:103353944	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-5.66	7.22e-08	-0.31	-0.42	Migraine;	chr10:103356299	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-5.66	7.22e-08	-0.31	-0.42	Migraine;	chr10:103358705	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-5.66	7.22e-08	-0.31	-0.42	Migraine;	chr10:103367951	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-5.66	7.22e-08	-0.31	-0.42	Migraine;	chr10:103384531	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-5.65	7.64e-08	-0.32	-0.42	Migraine;	chr10:103278698	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-5.64	7.82e-08	-0.31	-0.42	Migraine;	chr10:103395309	chr10:103394301~103394322:-
PAAD	cis	rs7255436	0.898	rs7252574	MIMAT0021017	hsa-miR-4999-5p	5.61	9.23e-08	0.59	0.41	HDL cholesterol;	chr19:8376895	chr19:8389340~8389360:-
PAAD	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-5.59	9.98e-08	-0.31	-0.41	Migraine;	chr10:103297804	chr10:103394301~103394322:-
PAAD	cis	rs7255436	0.965	rs62117510	MIMAT0021017	hsa-miR-4999-5p	5.56	1.15e-07	0.59	0.41	HDL cholesterol;	chr19:8387729	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.965	rs28729307	MIMAT0021017	hsa-miR-4999-5p	5.56	1.15e-07	0.59	0.41	HDL cholesterol;	chr19:8387858	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.894	rs10413136	MIMAT0021017	hsa-miR-4999-5p	5.56	1.15e-07	0.59	0.41	HDL cholesterol;	chr19:8387995	chr19:8389340~8389360:-
PAAD	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	5.54	1.28e-07	0.32	0.41	Migraine;	chr10:103248169	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	5.54	1.28e-07	0.32	0.41	Migraine;	chr10:103249329	chr10:103394301~103394322:-
PAAD	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	5.53	1.34e-07	0.59	0.41	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	5.53	1.34e-07	0.59	0.41	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	5.52	1.39e-07	0.59	0.41	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
PAAD	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	5.5	1.53e-07	0.59	0.41	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
PAAD	cis	rs7255436	0.965	rs4044435	MIMAT0021017	hsa-miR-4999-5p	5.41	2.39e-07	0.57	0.4	HDL cholesterol;	chr19:8383293	chr19:8389340~8389360:-
PAAD	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	5.4	2.47e-07	0.31	0.4	Migraine;	chr10:103237257	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-5.38	2.73e-07	-0.3	-0.4	Migraine;	chr10:103348698	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-5.38	2.73e-07	-0.3	-0.4	Migraine;	chr10:103358719	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-5.38	2.73e-07	-0.3	-0.4	Migraine;	chr10:103367521	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-5.38	2.73e-07	-0.3	-0.4	Migraine;	chr10:103379204	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-5.38	2.73e-07	-0.3	-0.4	Migraine;	chr10:103386935	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-5.37	2.93e-07	-0.3	-0.4	Migraine;	chr10:103395888	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-5.34	3.33e-07	-0.3	-0.4	Migraine;	chr10:103299551	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-5.34	3.33e-07	-0.3	-0.4	Migraine;	chr10:103309363	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	5.27	4.66e-07	0.3	0.39	Migraine;	chr10:103241753	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	5.26	4.68e-07	0.31	0.39	Migraine;	chr10:103242040	chr10:103394301~103394322:-
PAAD	cis	rs7894407	0.856	rs10883855	MIMAT0005951	hsa-miR-1307-3p	-5.13	8.48e-07	-0.29	-0.38	White matter hyperintensity burden;	chr10:103332690	chr10:103394301~103394322:-
PAAD	cis	rs7255436	0.965	rs2042900	MIMAT0021017	hsa-miR-4999-5p	5.12	8.95e-07	0.55	0.38	HDL cholesterol;	chr19:8374818	chr19:8389340~8389360:-
PAAD	cis	rs7894407	0.856	rs7093667	MIMAT0005951	hsa-miR-1307-3p	-5.08	1.08e-06	-0.29	-0.38	White matter hyperintensity burden;	chr10:103320818	chr10:103394301~103394322:-
PAAD	cis	rs7894407	0.76	rs1163085	MIMAT0005951	hsa-miR-1307-3p	-5.08	1.09e-06	-0.29	-0.38	White matter hyperintensity burden;	chr10:103279484	chr10:103394301~103394322:-
PAAD	cis	rs7829975	0.617	rs4841071	MIMAT0019728	hsa-miR-4660	5.05	1.22e-06	0.47	0.38	Mood instability;	chr8:8933634	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.617	rs4841072	MIMAT0019728	hsa-miR-4660	-5.05	1.24e-06	-0.47	-0.38	Mood instability;	chr8:8933743	chr8:9048453~9048475:+
PAAD	cis	rs1867631	0.959	rs11208914	MIMAT0014979	hsa-miR-3117-3p	-5.01	1.52e-06	-0.5	-0.38	Menopause (age at onset);	chr1:66584045	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	4.99	1.6e-06	0.5	0.37	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
PAAD	cis	rs7894407	1	rs7894407	MIMAT0005951	hsa-miR-1307-3p	4.99	1.61e-06	0.3	0.37	White matter hyperintensity burden;	chr10:103416422	chr10:103394301~103394322:-
PAAD	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-4.99	1.61e-06	-0.5	-0.37	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-4.99	1.61e-06	-0.5	-0.37	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
PAAD	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-4.99	1.61e-06	-0.5	-0.37	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
PAAD	cis	rs1867631	1	rs1867631	MIMAT0014979	hsa-miR-3117-3p	-4.98	1.69e-06	-0.5	-0.37	Menopause (age at onset);	chr1:66580443	chr1:66628485~66628505:+
PAAD	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	4.98	1.73e-06	0.5	0.37	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
PAAD	cis	rs7829975	0.582	rs6982832	MIMAT0019728	hsa-miR-4660	-4.97	1.78e-06	-0.46	-0.37	Mood instability;	chr8:8934707	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.582	rs6983150	MIMAT0019728	hsa-miR-4660	-4.97	1.78e-06	-0.46	-0.37	Mood instability;	chr8:8934916	chr8:9048453~9048475:+
PAAD	cis	rs7894407	0.76	rs4917386	MIMAT0005951	hsa-miR-1307-3p	4.95	1.98e-06	0.29	0.37	White matter hyperintensity burden;	chr10:103247771	chr10:103394301~103394322:-
PAAD	cis	rs453301	0.657	rs36056437	MIMAT0019728	hsa-miR-4660	-4.94	2e-06	-0.47	-0.37	Joint mobility (Beighton score);	chr8:8935355	chr8:9048453~9048475:+
PAAD	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-4.94	2.06e-06	-0.49	-0.37	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
PAAD	cis	rs7894407	0.76	rs1163072	MIMAT0005951	hsa-miR-1307-3p	4.91	2.31e-06	0.28	0.37	White matter hyperintensity burden;	chr10:103264621	chr10:103394301~103394322:-
PAAD	cis	rs7894407	0.892	rs10883859	MIMAT0005951	hsa-miR-1307-3p	4.9	2.4e-06	0.29	0.37	White matter hyperintensity burden;	chr10:103368377	chr10:103394301~103394322:-
PAAD	cis	rs453301	0.598	rs2921383	MIMAT0019728	hsa-miR-4660	4.9	2.47e-06	0.44	0.37	Joint mobility (Beighton score);	chr8:9034711	chr8:9048453~9048475:+
PAAD	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-4.89	2.56e-06	-0.52	-0.37	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-4.89	2.57e-06	-0.48	-0.37	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
PAAD	cis	rs453301	0.597	rs7001187	MIMAT0019728	hsa-miR-4660	-4.8	3.73e-06	-0.46	-0.36	Joint mobility (Beighton score);	chr8:8935272	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.631	rs13250781	MIMAT0019728	hsa-miR-4660	-4.8	3.73e-06	-0.46	-0.36	Joint mobility (Beighton score);	chr8:8935833	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-4.8	3.8e-06	-0.28	-0.36	Migraine;	chr10:103307280	chr10:103394301~103394322:-
PAAD	cis	rs453301	0.631	rs28572014	MIMAT0019728	hsa-miR-4660	-4.77	4.35e-06	-0.46	-0.36	Joint mobility (Beighton score);	chr8:8936097	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.624	rs2979265	MIMAT0019728	hsa-miR-4660	4.76	4.51e-06	0.44	0.36	Joint mobility (Beighton score);	chr8:9001207	chr8:9048453~9048475:+
PAAD	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-4.73	5.14e-06	-0.49	-0.36	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
PAAD	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-4.73	5.14e-06	-0.49	-0.36	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
PAAD	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-4.73	5.14e-06	-0.49	-0.36	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
PAAD	cis	rs453301	0.631	rs17700611	MIMAT0019728	hsa-miR-4660	-4.7	5.71e-06	-0.46	-0.36	Joint mobility (Beighton score);	chr8:8936144	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-4.69	6e-06	-0.28	-0.35	Migraine;	chr10:103375562	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-4.69	6e-06	-0.28	-0.35	Migraine;	chr10:103389790	chr10:103394301~103394322:-
PAAD	cis	rs453301	0.631	rs7843369	MIMAT0019728	hsa-miR-4660	-4.69	6.03e-06	-0.45	-0.35	Joint mobility (Beighton score);	chr8:8940276	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.631	rs11779804	MIMAT0019728	hsa-miR-4660	-4.69	6.03e-06	-0.45	-0.35	Joint mobility (Beighton score);	chr8:8940442	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	4.69	6.05e-06	0.27	0.35	Migraine;	chr10:103367830	chr10:103394301~103394322:-
PAAD	cis	rs453301	0.624	rs6987558	MIMAT0019728	hsa-miR-4660	4.66	6.78e-06	0.43	0.35	Joint mobility (Beighton score);	chr8:9005011	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.579	rs10096850	MIMAT0019728	hsa-miR-4660	-4.65	7.02e-06	-0.45	-0.35	Joint mobility (Beighton score);	chr8:8940712	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.582	rs448231	MIMAT0019728	hsa-miR-4660	-4.63	7.67e-06	-0.43	-0.35	Mood instability;	chr8:8932549	chr8:9048453~9048475:+
PAAD	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-4.62	8.12e-06	-0.27	-0.35	Migraine;	chr10:103279291	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-4.62	8.17e-06	-0.38	-0.35	Migraine;	chr10:103284207	chr10:103394341~103394361:-
PAAD	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-4.61	8.38e-06	-0.27	-0.35	Migraine;	chr10:103273985	chr10:103394301~103394322:-
PAAD	cis	rs7829975	0.606	rs6422352	MIMAT0019728	hsa-miR-4660	-4.61	8.4e-06	-0.44	-0.35	Mood instability;	chr8:8936683	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.606	rs891570	MIMAT0019728	hsa-miR-4660	-4.61	8.4e-06	-0.44	-0.35	Mood instability;	chr8:8936944	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.606	rs10112585	MIMAT0019728	hsa-miR-4660	-4.61	8.59e-06	-0.44	-0.35	Mood instability;	chr8:8937520	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.606	rs11776838	MIMAT0019728	hsa-miR-4660	-4.6	8.64e-06	-0.44	-0.35	Mood instability;	chr8:8937291	chr8:9048453~9048475:+
PAAD	cis	rs75358501	0.901	rs17212861	MIMAT0014995	hsa-miR-3130-5p	-4.6	8.68e-06	-0.74	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206725849	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.901	rs17212861	MIMAT0014995_1	hsa-miR-3130-5p	-4.6	8.68e-06	-0.74	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206725849	chr2:206783246~206783266:+
PAAD	cis	rs75358501	0.901	rs115783504	MIMAT0014995	hsa-miR-3130-5p	-4.6	8.68e-06	-0.74	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206725950	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.901	rs115783504	MIMAT0014995_1	hsa-miR-3130-5p	-4.6	8.68e-06	-0.74	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206725950	chr2:206783246~206783266:+
PAAD	cis	rs7829975	0.572	rs7005000	MIMAT0019728	hsa-miR-4660	-4.6	8.69e-06	-0.44	-0.35	Mood instability;	chr8:8939092	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-4.6	8.76e-06	-0.38	-0.35	Migraine;	chr10:103283532	chr10:103394341~103394361:-
PAAD	cis	rs453301	0.605	rs7843024	MIMAT0019728	hsa-miR-4660	-4.59	8.99e-06	-0.46	-0.35	Joint mobility (Beighton score);	chr8:8942466	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.631	rs7843789	MIMAT0019728	hsa-miR-4660	-4.59	8.99e-06	-0.46	-0.35	Joint mobility (Beighton score);	chr8:8943051	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.631	rs4840376	MIMAT0019728	hsa-miR-4660	-4.59	8.99e-06	-0.46	-0.35	Joint mobility (Beighton score);	chr8:8944591	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	4.57	9.84e-06	0.27	0.35	Migraine;	chr10:103347713	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-4.56	1.05e-05	-0.27	-0.35	Migraine;	chr10:103305652	chr10:103394301~103394322:-
PAAD	cis	rs453301	0.631	rs11780774	MIMAT0019728	hsa-miR-4660	-4.53	1.17e-05	-0.46	-0.34	Joint mobility (Beighton score);	chr8:8941601	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	4.53	1.18e-05	0.27	0.34	Migraine;	chr10:103402122	chr10:103394301~103394322:-
PAAD	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-4.53	1.2e-05	-0.6	-0.34	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
PAAD	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-4.53	1.2e-05	-0.6	-0.34	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
PAAD	cis	rs7894407	0.504	rs7089271	MIMAT0005951	hsa-miR-1307-3p	-4.53	1.2e-05	-0.27	-0.34	White matter hyperintensity burden;	chr10:103417157	chr10:103394301~103394322:-
PAAD	cis	rs7829975	0.567	rs6601273	MIMAT0019728	hsa-miR-4660	-4.5	1.31e-05	-0.43	-0.34	Mood instability;	chr8:8939009	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.606	rs7819827	MIMAT0019728	hsa-miR-4660	-4.5	1.31e-05	-0.43	-0.34	Mood instability;	chr8:8939545	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.509	rs7838674	MIMAT0019728	hsa-miR-4660	-4.5	1.31e-05	-0.43	-0.34	Mood instability;	chr8:8939563	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.573	rs7842359	MIMAT0019728	hsa-miR-4660	-4.5	1.31e-05	-0.43	-0.34	Mood instability;	chr8:8939568	chr8:9048453~9048475:+
PAAD	cis	rs1964356	0.524	rs7839585	MIMAT0019728	hsa-miR-4660	-4.5	1.32e-05	-0.44	-0.34	Mean corpuscular volume;	chr8:8996725	chr8:9048453~9048475:+
PAAD	cis	rs7894407	0.634	rs56060736	MIMAT0005951	hsa-miR-1307-3p	4.49	1.38e-05	0.29	0.34	White matter hyperintensity burden;	chr10:103310496	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-4.49	1.38e-05	-0.36	-0.34	Migraine;	chr10:103273871	chr10:103394341~103394361:-
PAAD	cis	rs453301	0.598	rs10104303	MIMAT0019728	hsa-miR-4660	4.49	1.39e-05	0.4	0.34	Joint mobility (Beighton score);	chr8:8977018	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-4.48	1.43e-05	-0.36	-0.34	Migraine;	chr10:103279822	chr10:103394341~103394361:-
PAAD	cis	rs4547160	0.962	rs12229749	MIMAT0004585	hsa-let-7i-3p	-4.47	1.49e-05	-0.32	-0.34	Morning vs. evening chronotype;	chr12:63109667	chr12:62603747~62603768:+
PAAD	cis	rs453301	0.624	rs2288671	MIMAT0019728	hsa-miR-4660	4.45	1.65e-05	0.41	0.34	Joint mobility (Beighton score);	chr8:9003384	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.598	rs1025395	MIMAT0019728	hsa-miR-4660	4.45	1.67e-05	0.4	0.34	Joint mobility (Beighton score);	chr8:8979093	chr8:9048453~9048475:+
PAAD	cis	rs7894407	0.675	rs72846190	MIMAT0005951	hsa-miR-1307-3p	4.43	1.78e-05	0.28	0.34	White matter hyperintensity burden;	chr10:103319660	chr10:103394301~103394322:-
PAAD	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-4.42	1.86e-05	-0.26	-0.34	Migraine;	chr10:103273258	chr10:103394301~103394322:-
PAAD	cis	rs7829975	0.572	rs28730413	MIMAT0019728	hsa-miR-4660	-4.41	1.92e-05	-0.41	-0.34	Mood instability;	chr8:8937937	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.522	rs1964356	MIMAT0019728	hsa-miR-4660	4.39	2.07e-05	0.42	0.33	Joint mobility (Beighton score);	chr8:8995760	chr8:9048453~9048475:+
PAAD	cis	rs2075671	0.818	rs10953302	MIMAT0000081	hsa-miR-25-3p	4.38	2.22e-05	0.35	0.33	Other erythrocyte phenotypes;	chr7:100767944	chr7:100093571~100093592:-
PAAD	cis	rs453301	0.624	rs4841083	MIMAT0019728	hsa-miR-4660	4.38	2.23e-05	0.41	0.33	Joint mobility (Beighton score);	chr8:9012918	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.624	rs2979256	MIMAT0019728	hsa-miR-4660	4.37	2.24e-05	0.41	0.33	Joint mobility (Beighton score);	chr8:9014200	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.653	rs7016139	MIMAT0019728	hsa-miR-4660	-4.37	2.28e-05	-0.41	-0.33	Joint mobility (Beighton score);	chr8:9037960	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.653	rs7853	MIMAT0019728	hsa-miR-4660	4.35	2.43e-05	0.41	0.33	Joint mobility (Beighton score);	chr8:9033304	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-4.35	2.45e-05	-0.38	-0.33	Migraine;	chr10:103286250	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-4.35	2.45e-05	-0.38	-0.33	Migraine;	chr10:103286932	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-4.35	2.45e-05	-0.38	-0.33	Migraine;	chr10:103295206	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-4.35	2.45e-05	-0.38	-0.33	Migraine;	chr10:103296155	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-4.35	2.45e-05	-0.38	-0.33	Migraine;	chr10:103315955	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-4.35	2.45e-05	-0.38	-0.33	Migraine;	chr10:103365694	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-4.35	2.45e-05	-0.38	-0.33	Migraine;	chr10:103369141	chr10:103394341~103394361:-
PAAD	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	4.34	2.53e-05	0.52	0.33	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
PAAD	cis	rs2075671	0.818	rs10953303	MIMAT0000081	hsa-miR-25-3p	4.34	2.61e-05	0.35	0.33	Other erythrocyte phenotypes;	chr7:100767990	chr7:100093571~100093592:-
PAAD	cis	rs1964356	0.967	rs2953802	MIMAT0019728	hsa-miR-4660	4.32	2.75e-05	0.41	0.33	Mean corpuscular volume;	chr8:8994371	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.572	rs28446104	MIMAT0019728	hsa-miR-4660	-4.32	2.77e-05	-0.41	-0.33	Mood instability;	chr8:8938391	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-4.31	2.85e-05	-0.37	-0.33	Migraine;	chr10:103394332	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-4.3	3.03e-05	-0.37	-0.33	Migraine;	chr10:103254113	chr10:103394341~103394361:-
PAAD	cis	rs453301	0.624	rs2915251	MIMAT0019728	hsa-miR-4660	4.29	3.12e-05	0.4	0.33	Joint mobility (Beighton score);	chr8:9009901	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	4.29	3.21e-05	0.35	0.33	Migraine;	chr10:103238157	chr10:103394341~103394361:-
PAAD	cis	rs7084783	0.622	rs61606504	MIMAT0005951	hsa-miR-1307-3p	4.28	3.26e-05	0.25	0.33	Fear of pain;	chr10:103589010	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	4.28	3.33e-05	0.38	0.33	Migraine;	chr10:103263177	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-4.26	3.53e-05	-0.35	-0.33	Migraine;	chr10:103241568	chr10:103394341~103394361:-
PAAD	cis	rs453301	0.653	rs1045529	MIMAT0019728	hsa-miR-4660	-4.25	3.64e-05	-0.41	-0.33	Joint mobility (Beighton score);	chr8:9032588	chr8:9048453~9048475:+
PAAD	cis	rs730570	1	rs730570	MIMAT0003331	hsa-miR-655-3p	-4.25	3.72e-05	-0.36	-0.32	Type 2 diabetes;	chr14:100676553	chr14:101049610~101049631:+
PAAD	cis	rs453301	0.592	rs4841084	MIMAT0019728	hsa-miR-4660	4.25	3.74e-05	0.41	0.32	Joint mobility (Beighton score);	chr8:9026395	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.653	rs2956244	MIMAT0019728	hsa-miR-4660	4.25	3.74e-05	0.41	0.32	Joint mobility (Beighton score);	chr8:9027656	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.624	rs2288673	MIMAT0019728	hsa-miR-4660	4.24	3.87e-05	0.41	0.32	Joint mobility (Beighton score);	chr8:9002766	chr8:9048453~9048475:+
PAAD	cis	rs7084783	0.6	rs11191738	MIMAT0005951	hsa-miR-1307-3p	-4.24	3.91e-05	-0.25	-0.32	Fear of pain;	chr10:103586227	chr10:103394301~103394322:-
PAAD	cis	rs7084783	0.5	rs4918024	MIMAT0005951	hsa-miR-1307-3p	4.24	3.93e-05	0.26	0.32	Fear of pain;	chr10:103582103	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-4.23	4.01e-05	-0.37	-0.32	Migraine;	chr10:103415374	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-4.23	4.04e-05	-0.35	-0.32	Migraine;	chr10:103289348	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-4.23	4.04e-05	-0.35	-0.32	Migraine;	chr10:103292867	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-4.23	4.04e-05	-0.35	-0.32	Migraine;	chr10:103293183	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-4.23	4.04e-05	-0.35	-0.32	Migraine;	chr10:103293219	chr10:103394341~103394361:-
PAAD	cis	rs730570	0.891	rs4900470	MIMAT0003331	hsa-miR-655-3p	-4.2	4.54e-05	-0.34	-0.32	Type 2 diabetes;	chr14:100678359	chr14:101049610~101049631:+
PAAD	cis	rs12145833	0.538	rs12042959	MIMAT0019761	hsa-miR-4677-3p	4.19	4.74e-05	0.58	0.32	Obesity (early onset extreme);	chr1:243369971	chr1:243346225~243346246:+
PAAD	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	4.19	4.75e-05	0.36	0.32	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
PAAD	cis	rs7084783	0.519	rs4917395	MIMAT0005951	hsa-miR-1307-3p	4.18	4.9e-05	0.25	0.32	Fear of pain;	chr10:103591625	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-4.17	5.16e-05	-0.37	-0.32	Migraine;	chr10:103338267	chr10:103394341~103394361:-
PAAD	cis	rs72848980	0.582	rs4917391	MIMAT0005951	hsa-miR-1307-3p	4.17	5.18e-05	0.28	0.32	White matter hyperintensity burden;	chr10:103522907	chr10:103394301~103394322:-
PAAD	cis	rs1964356	0.967	rs17701675	MIMAT0019728	hsa-miR-4660	-4.16	5.23e-05	-0.39	-0.32	Mean corpuscular volume;	chr8:8993123	chr8:9048453~9048475:+
PAAD	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-4.15	5.54e-05	-0.35	-0.32	Migraine;	chr10:103353944	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-4.15	5.54e-05	-0.35	-0.32	Migraine;	chr10:103356299	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-4.15	5.54e-05	-0.35	-0.32	Migraine;	chr10:103358705	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-4.15	5.54e-05	-0.35	-0.32	Migraine;	chr10:103367951	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-4.15	5.54e-05	-0.35	-0.32	Migraine;	chr10:103384531	chr10:103394341~103394361:-
PAAD	cis	rs7084783	0.519	rs10879	MIMAT0005951	hsa-miR-1307-3p	-4.14	5.7e-05	-0.25	-0.32	Fear of pain;	chr10:103594799	chr10:103394301~103394322:-
PAAD	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-4.13	5.85e-05	-0.34	-0.32	Migraine;	chr10:103395309	chr10:103394341~103394361:-
PAAD	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-4.13	5.91e-05	-0.51	-0.32	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
PAAD	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-4.13	5.91e-05	-0.51	-0.32	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
PAAD	cis	rs7084783	0.538	rs7067892	MIMAT0005951	hsa-miR-1307-3p	4.13	5.98e-05	0.25	0.32	Fear of pain;	chr10:103579941	chr10:103394301~103394322:-
PAAD	cis	rs7084783	0.519	rs1047425	MIMAT0005951	hsa-miR-1307-3p	4.12	6.11e-05	0.25	0.32	Fear of pain;	chr10:103585444	chr10:103394301~103394322:-
PAAD	cis	rs730570	1	rs10141733	MIMAT0003331	hsa-miR-655-3p	4.11	6.41e-05	0.34	0.32	Type 2 diabetes;	chr14:100676314	chr14:101049610~101049631:+
PAAD	cis	rs75358501	1	rs75358501	MIMAT0014995	hsa-miR-3130-5p	-4.11	6.49e-05	-0.59	-0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783276~206783296:-
PAAD	cis	rs75358501	1	rs75358501	MIMAT0014995_1	hsa-miR-3130-5p	-4.11	6.49e-05	-0.59	-0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783246~206783266:+
PAAD	cis	rs12145833	0.679	rs12029086	MIMAT0019761	hsa-miR-4677-3p	4.11	6.53e-05	0.56	0.32	Obesity (early onset extreme);	chr1:243401420	chr1:243346225~243346246:+
PAAD	cis	rs1867631	0.585	rs12062570	MIMAT0014979	hsa-miR-3117-3p	-4.09	6.91e-05	-0.39	-0.31	Menopause (age at onset);	chr1:66620602	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.585	rs4655639	MIMAT0014979	hsa-miR-3117-3p	-4.09	6.91e-05	-0.39	-0.31	Menopause (age at onset);	chr1:66623407	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.585	rs5008753	MIMAT0014979	hsa-miR-3117-3p	-4.09	6.91e-05	-0.39	-0.31	Menopause (age at onset);	chr1:66626565	chr1:66628485~66628505:+
PAAD	cis	rs4547160	0.962	rs7308703	MIMAT0004585	hsa-let-7i-3p	-4.09	6.96e-05	-0.31	-0.31	Morning vs. evening chronotype;	chr12:63101213	chr12:62603747~62603768:+
PAAD	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-4.09	7.07e-05	-0.52	-0.31	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
PAAD	cis	rs7084783	0.519	rs2281584	MIMAT0005951	hsa-miR-1307-3p	4.08	7.29e-05	0.24	0.31	Fear of pain;	chr10:103599223	chr10:103394301~103394322:-
PAAD	cis	rs6993244	1	rs6993244	MIMAT0019728	hsa-miR-4660	4.07	7.38e-05	0.39	0.31	Mean corpuscular hemoglobin;	chr8:9005549	chr8:9048453~9048475:+
PAAD	cis	rs7829975	0.606	rs6601274	MIMAT0019728	hsa-miR-4660	-4.07	7.44e-05	-0.39	-0.31	Mood instability;	chr8:8941549	chr8:9048453~9048475:+
PAAD	cis	rs12145833	0.619	rs10927006	MIMAT0019761	hsa-miR-4677-3p	4.06	7.67e-05	0.56	0.31	Obesity (early onset extreme);	chr1:243394357	chr1:243346225~243346246:+
PAAD	cis	rs1063857	0.656	rs216293	MIMAT0000617	hsa-miR-200c-3p	4.06	7.73e-05	0.21	0.31	Coagulation factor levels;vWF levels;	chr12:6044493	chr12:6963742~6963764:+
PAAD	cis	rs453301	0.653	rs1562211	MIMAT0019728	hsa-miR-4660	-4.06	7.84e-05	-0.4	-0.31	Joint mobility (Beighton score);	chr8:9044914	chr8:9048453~9048475:+
PAAD	cis	rs12460587	0.587	rs10415150	MIMAT0004485	hsa-let-7e-3p	-4.06	7.9e-05	-0.27	-0.31	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction);	chr19:52101372	chr19:51692838~51692859:+
PAAD	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-4.05	8.07e-05	-0.44	-0.31	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
PAAD	cis	rs1867631	0.585	rs9787219	MIMAT0014979	hsa-miR-3117-3p	-4.05	8.08e-05	-0.38	-0.31	Menopause (age at onset);	chr1:66614476	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.585	rs11208922	MIMAT0014979	hsa-miR-3117-3p	-4.05	8.08e-05	-0.38	-0.31	Menopause (age at onset);	chr1:66614543	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.585	rs4655642	MIMAT0014979	hsa-miR-3117-3p	-4.05	8.1e-05	-0.38	-0.31	Menopause (age at onset);	chr1:66624400	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.585	rs11208940	MIMAT0014979	hsa-miR-3117-3p	4.04	8.58e-05	0.39	0.31	Menopause (age at onset);	chr1:66661559	chr1:66628485~66628505:+
PAAD	cis	rs72848980	0.582	rs72848951	MIMAT0005951	hsa-miR-1307-3p	4.03	8.82e-05	0.28	0.31	White matter hyperintensity burden;	chr10:103517410	chr10:103394301~103394322:-
PAAD	cis	rs72848980	0.582	rs72848953	MIMAT0005951	hsa-miR-1307-3p	4.03	8.82e-05	0.28	0.31	White matter hyperintensity burden;	chr10:103517411	chr10:103394301~103394322:-
PAAD	cis	rs453301	0.653	rs7005133	MIMAT0019728	hsa-miR-4660	4.03	8.92e-05	0.4	0.31	Joint mobility (Beighton score);	chr8:9043712	chr8:9048453~9048475:+
PAAD	cis	rs453301	0.653	rs11784393	MIMAT0019728	hsa-miR-4660	4.02	9.08e-05	0.4	0.31	Joint mobility (Beighton score);	chr8:9045624	chr8:9048453~9048475:+
PAAD	cis	rs1867631	0.585	rs12094526	MIMAT0014979	hsa-miR-3117-3p	-4.02	9.19e-05	-0.38	-0.31	Menopause (age at onset);	chr1:66660431	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.585	rs6670827	MIMAT0014979	hsa-miR-3117-3p	-4.02	9.19e-05	-0.38	-0.31	Menopause (age at onset);	chr1:66661323	chr1:66628485~66628505:+
PAAD	cis	rs1867631	0.585	rs6694782	MIMAT0014979	hsa-miR-3117-3p	4.02	9.19e-05	0.38	0.31	Menopause (age at onset);	chr1:66661079	chr1:66628485~66628505:+
PAAD	cis	rs7084783	0.519	rs4918025	MIMAT0005951	hsa-miR-1307-3p	4.01	9.34e-05	0.25	0.31	Fear of pain;	chr10:103583109	chr10:103394301~103394322:-
PAAD	cis	rs8007846	0.569	rs11848463	MIMAT0004808	hsa-miR-625-3p	4.01	9.39e-05	0.29	0.31	Multiple sclerosis--Brain Glutamate Levels;	chr14:65790576	chr14:65471153~65471174:+
PAAD	cis	rs6753739	1	rs6753739	MIMAT0014996	hsa-miR-3131	4.01	9.41e-05	0.34	0.31	Height;	chr2:219164178	chr2:219058725~219058747:-
PAAD	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	4.01	9.44e-05	0.34	0.31	Migraine;	chr10:103261506	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-4.01	9.44e-05	-0.34	-0.31	Migraine;	chr10:103262005	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-4.01	9.44e-05	-0.34	-0.31	Migraine;	chr10:103270083	chr10:103394341~103394361:-
PAAD	cis	rs7829975	0.517	rs12542733	MIMAT0019728	hsa-miR-4660	-4.01	9.53e-05	-0.37	-0.31	Mood instability;	chr8:8967348	chr8:9048453~9048475:+
PAAD	cis	rs8007846	0.569	rs11848443	MIMAT0004808	hsa-miR-625-3p	-4.01	9.61e-05	-0.29	-0.31	Multiple sclerosis--Brain Glutamate Levels;	chr14:65790701	chr14:65471153~65471174:+
PAAD	cis	rs8007846	0.569	rs11848444	MIMAT0004808	hsa-miR-625-3p	-4.01	9.61e-05	-0.29	-0.31	Multiple sclerosis--Brain Glutamate Levels;	chr14:65790749	chr14:65471153~65471174:+
PAAD	cis	rs6753739	0.826	rs6732562	MIMAT0014996	hsa-miR-3131	4	9.69e-05	0.35	0.31	Height;	chr2:219102140	chr2:219058725~219058747:-
PAAD	cis	rs1063857	0.656	rs216291	MIMAT0000617	hsa-miR-200c-3p	4	9.97e-05	0.2	0.31	Coagulation factor levels;vWF levels;	chr12:6042707	chr12:6963742~6963764:+
PAAD	cis	rs7084783	0.519	rs10883885	MIMAT0005951	hsa-miR-1307-3p	3.99	0.000101	0.25	0.31	Fear of pain;	chr10:103574095	chr10:103394301~103394322:-
PAAD	cis	rs4547160	0.788	rs12227007	MIMAT0004585	hsa-let-7i-3p	-3.99	0.000102	-0.3	-0.31	Morning vs. evening chronotype;	chr12:63090930	chr12:62603747~62603768:+
PAAD	cis	rs7829975	0.755	rs3789849	MIMAT0019728	hsa-miR-4660	3.99	0.000102	0.39	0.31	Mood instability;	chr8:8829544	chr8:9048453~9048475:+
PAAD	cis	rs6753739	0.871	rs6436114	MIMAT0014996	hsa-miR-3131	3.98	0.000104	0.34	0.31	Height;	chr2:219138112	chr2:219058725~219058747:-
PAAD	cis	rs6753739	0.627	rs2293070	MIMAT0014996	hsa-miR-3131	3.98	0.000106	0.34	0.31	Height;	chr2:219158882	chr2:219058725~219058747:-
PAAD	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-3.97	0.000109	-0.33	-0.31	Migraine;	chr10:103299082	chr10:103394341~103394361:-
PAAD	cis	rs4547160	0.962	rs12229749	MIMAT0000415	hsa-let-7i-5p	-3.97	0.000112	-0.34	-0.31	Morning vs. evening chronotype;	chr12:63109667	chr12:62603691~62603712:+
PAAD	cis	rs6753739	0.826	rs7599778	MIMAT0014996	hsa-miR-3131	3.96	0.000114	0.35	0.31	Height;	chr2:219096938	chr2:219058725~219058747:-
PAAD	cis	rs12145833	0.679	rs10927010	MIMAT0019761	hsa-miR-4677-3p	-3.96	0.000115	-0.54	-0.3	Obesity (early onset extreme);	chr1:243415510	chr1:243346225~243346246:+
PAAD	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-3.95	0.000118	-0.34	-0.3	Migraine;	chr10:103278698	chr10:103394341~103394361:-
PAAD	cis	rs6753739	0.784	rs10168527	MIMAT0014996	hsa-miR-3131	3.95	0.00012	0.34	0.3	Height;	chr2:219107653	chr2:219058725~219058747:-
PAAD	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-3.95	0.000121	-0.34	-0.3	Migraine;	chr10:103284400	chr10:103394341~103394361:-
PAAD	cis	rs6753739	0.871	rs1869802	MIMAT0014996	hsa-miR-3131	3.94	0.000121	0.34	0.3	Height;	chr2:219112311	chr2:219058725~219058747:-
PAAD	cis	rs11621975	0.57	rs67941660	MIMAT0002817	hsa-miR-495-3p	3.93	0.000129	0.49	0.3	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin;	chr14:101815149	chr14:101033804~101033825:+
PAAD	cis	rs4934494	0.822	rs3962370	MIMAT0000104	hsa-miR-107	3.92	0.000133	0.26	0.3	Red blood cell count;	chr10:89777763	chr10:89592756~89592778:-
PAAD	cis	rs4934494	0.727	rs1590566	MIMAT0000104	hsa-miR-107	3.92	0.000133	0.26	0.3	Red blood cell count;	chr10:89778781	chr10:89592756~89592778:-
PAAD	cis	rs6753739	0.871	rs6436110	MIMAT0014996	hsa-miR-3131	3.91	0.000137	0.34	0.3	Height;	chr2:219116231	chr2:219058725~219058747:-
PAAD	cis	rs6753739	0.871	rs10932796	MIMAT0014996	hsa-miR-3131	3.91	0.000138	0.34	0.3	Height;	chr2:219156790	chr2:219058725~219058747:-
PAAD	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	3.9	0.000141	0.35	0.3	Migraine;	chr10:103236031	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-3.9	0.000141	-0.33	-0.3	Migraine;	chr10:103317367	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-3.9	0.000141	-0.33	-0.3	Migraine;	chr10:103319682	chr10:103394341~103394361:-
PAAD	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	3.9	0.000142	0.33	0.3	Migraine;	chr10:103244344	chr10:103394341~103394361:-
PAAD	cis	rs453301	0.652	rs2043129	MIMAT0019728	hsa-miR-4660	3.9	0.000144	0.39	0.3	Joint mobility (Beighton score);	chr8:8967994	chr8:9048453~9048475:+
PAAD	cis	rs72848980	0.706	rs12261058	MIMAT0005951	hsa-miR-1307-3p	3.9	0.000145	0.28	0.3	White matter hyperintensity burden;	chr10:103564191	chr10:103394301~103394322:-
PAAD	cis	rs2075671	0.582	rs3891039	MIMAT0000081	hsa-miR-25-3p	3.9	0.000145	0.31	0.3	Other erythrocyte phenotypes;	chr7:100749031	chr7:100093571~100093592:-
PAAD	cis	rs453301	0.686	rs3989373	MIMAT0019728	hsa-miR-4660	-3.89	0.000146	-0.4	-0.3	Joint mobility (Beighton score);	chr8:9053798	chr8:9048453~9048475:+
PAAD	cis	rs12145833	0.679	rs12048498	MIMAT0019761	hsa-miR-4677-3p	3.89	0.000151	0.56	0.3	Obesity (early onset extreme);	chr1:243387345	chr1:243346225~243346246:+
PAAD	cis	rs7084783	0.507	rs10883893	MIMAT0005951	hsa-miR-1307-3p	3.89	0.000151	0.22	0.3	Fear of pain;	chr10:103653885	chr10:103394301~103394322:-
PAAD	cis	rs2075671	0.903	rs62483592	MIMAT0000081	hsa-miR-25-3p	3.88	0.000156	0.32	0.3	Other erythrocyte phenotypes;	chr7:100749826	chr7:100093571~100093592:-
PAAD	cis	rs453301	0.686	rs6601281	MIMAT0019728	hsa-miR-4660	-3.87	0.000158	-0.4	-0.3	Joint mobility (Beighton score);	chr8:9053494	chr8:9048453~9048475:+
PAAD	cis	rs4680534	0.512	rs6441282	MIMAT0004586	hsa-miR-15b-3p	-3.87	0.000159	-0.25	-0.3	Multiple sclerosis;	chr3:159981289	chr3:160404645~160404666:+
PAAD	cis	rs6753739	0.871	rs9784128	MIMAT0014996	hsa-miR-3131	-3.87	0.000161	-0.34	-0.3	Height;	chr2:219113916	chr2:219058725~219058747:-
PAAD	cis	rs6753739	0.871	rs6436113	MIMAT0014996	hsa-miR-3131	3.87	0.000161	0.34	0.3	Height;	chr2:219120176	chr2:219058725~219058747:-
PAAD	cis	rs6753739	0.826	rs6711613	MIMAT0014996	hsa-miR-3131	3.87	0.000163	0.34	0.3	Height;	chr2:219082969	chr2:219058725~219058747:-
PAAD	cis	rs6753739	0.784	rs11690649	MIMAT0014996	hsa-miR-3131	3.87	0.000163	0.34	0.3	Height;	chr2:219083049	chr2:219058725~219058747:-
PAAD	cis	rs6753739	0.826	rs10164493	MIMAT0014996	hsa-miR-3131	3.87	0.000163	0.34	0.3	Height;	chr2:219083370	chr2:219058725~219058747:-
PAAD	cis	rs6753739	0.784	rs1378642	MIMAT0014996	hsa-miR-3131	3.87	0.000163	0.34	0.3	Height;	chr2:219085388	chr2:219058725~219058747:-
PAAD	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	3.86	0.000166	0.33	0.3	Migraine;	chr10:103242040	chr10:103394341~103394361:-
PAAD	cis	rs6753739	0.745	rs7572601	MIMAT0014996	hsa-miR-3131	3.86	0.000167	0.33	0.3	Height;	chr2:219154762	chr2:219058725~219058747:-
PAAD	cis	rs12145833	0.679	rs12037698	MIMAT0019761	hsa-miR-4677-3p	3.86	0.000167	0.53	0.3	Obesity (early onset extreme);	chr1:243421043	chr1:243346225~243346246:+
PAAD	cis	rs453301	0.686	rs6601280	MIMAT0019728	hsa-miR-4660	3.86	0.000169	0.4	0.3	Joint mobility (Beighton score);	chr8:9051726	chr8:9048453~9048475:+
PAAD	trans	rs7874161	0.501	rs4743037	MIMAT0003241	hsa-miR-576-5p	-6.31	2.91e-09	-0.58	-0.45	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);	chr9:106877689	chr4:109488713~109488734:+
PAAD	trans	rs7874161	0.526	rs4743034	MIMAT0003241	hsa-miR-576-5p	-6.3	3.01e-09	-0.58	-0.45	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);	chr9:106870072	chr4:109488713~109488734:+
PAAD	trans	rs7027110	0.738	rs4743033	MIMAT0003241	hsa-miR-576-5p	-6.15	6.37e-09	-0.61	-0.45	Height;	chr9:106865632	chr4:109488713~109488734:+
PAAD	trans	rs7027110	0.821	rs4743035	MIMAT0003241	hsa-miR-576-5p	-6.06	9.99e-09	-0.59	-0.44	Height;	chr9:106875003	chr4:109488713~109488734:+
PAAD	trans	rs7027110	0.779	rs9299130	MIMAT0003241	hsa-miR-576-5p	-6.06	9.99e-09	-0.59	-0.44	Height;	chr9:106875917	chr4:109488713~109488734:+
PAAD	trans	rs7027110	0.779	rs4743036	MIMAT0003241	hsa-miR-576-5p	-6.06	9.99e-09	-0.59	-0.44	Height;	chr9:106877615	chr4:109488713~109488734:+
PAAD	trans	rs7027110	0.779	rs4743038	MIMAT0003241	hsa-miR-576-5p	-6.06	9.99e-09	-0.59	-0.44	Height;	chr9:106883706	chr4:109488713~109488734:+
PAAD	trans	rs7027110	0.779	rs35460589	MIMAT0003241	hsa-miR-576-5p	-6.06	1.04e-08	-0.59	-0.44	Height;	chr9:106882030	chr4:109488713~109488734:+
PAAD	trans	rs7027110	0.779	rs35699219	MIMAT0003241	hsa-miR-576-5p	-6.06	1.04e-08	-0.59	-0.44	Height;	chr9:106882096	chr4:109488713~109488734:+
PAAD	trans	rs3008870	1	rs2815371	MIMAT0004610	hsa-miR-150-3p	6.05	1.08e-08	0.44	0.44	Lymphocyte percentage of white cells;	chr1:67038630	chr19:49500797~49500818:-
PAAD	trans	rs820077	0.736	rs2762336	MIMAT0015045	hsa-miR-3170	-6.05	1.09e-08	-0.82	-0.44	Systemic lupus erythematosus;	chr6:35070439	chr13:98208533~98208554:+
PAAD	trans	rs3008870	1	rs2815357	MIMAT0004610	hsa-miR-150-3p	6.04	1.14e-08	0.44	0.44	Lymphocyte percentage of white cells;	chr1:67026171	chr19:49500797~49500818:-
PAAD	trans	rs3008870	1	rs2815361	MIMAT0004610	hsa-miR-150-3p	6.04	1.14e-08	0.44	0.44	Lymphocyte percentage of white cells;	chr1:67028908	chr19:49500797~49500818:-
PAAD	trans	rs3008870	1	rs2755250	MIMAT0004610	hsa-miR-150-3p	6.04	1.14e-08	0.44	0.44	Lymphocyte percentage of white cells;	chr1:67029600	chr19:49500797~49500818:-
PAAD	trans	rs820077	0.61	rs2177382	MIMAT0015045	hsa-miR-3170	-6.02	1.23e-08	-0.78	-0.44	Systemic lupus erythematosus;	chr6:35082729	chr13:98208533~98208554:+
PAAD	trans	rs3008870	1	rs2009319	MIMAT0004610	hsa-miR-150-3p	6.02	1.25e-08	0.44	0.44	Lymphocyte percentage of white cells;	chr1:67015387	chr19:49500797~49500818:-
PAAD	trans	rs3008870	1	rs2755248	MIMAT0004610	hsa-miR-150-3p	6.02	1.25e-08	0.44	0.44	Lymphocyte percentage of white cells;	chr1:67026941	chr19:49500797~49500818:-
PAAD	trans	rs3008870	0.883	rs2755249	MIMAT0004610	hsa-miR-150-3p	6.02	1.25e-08	0.44	0.44	Lymphocyte percentage of white cells;	chr1:67027979	chr19:49500797~49500818:-
PAAD	trans	rs3008870	0.959	rs2815359	MIMAT0004610	hsa-miR-150-3p	6.02	1.25e-08	0.44	0.44	Lymphocyte percentage of white cells;	chr1:67028691	chr19:49500797~49500818:-
PAAD	trans	rs820077	0.736	rs820069	MIMAT0015045	hsa-miR-3170	-6.02	1.27e-08	-0.82	-0.44	Systemic lupus erythematosus;	chr6:35072089	chr13:98208533~98208554:+
PAAD	trans	rs820077	0.736	rs820067	MIMAT0015045	hsa-miR-3170	-6.02	1.27e-08	-0.82	-0.44	Systemic lupus erythematosus;	chr6:35072437	chr13:98208533~98208554:+
PAAD	trans	rs820077	0.736	rs820066	MIMAT0015045	hsa-miR-3170	-6.02	1.27e-08	-0.82	-0.44	Systemic lupus erythematosus;	chr6:35072483	chr13:98208533~98208554:+
PAAD	trans	rs820077	0.668	rs820065	MIMAT0015045	hsa-miR-3170	-6.02	1.27e-08	-0.82	-0.44	Systemic lupus erythematosus;	chr6:35072643	chr13:98208533~98208554:+